JP2002516882A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002516882A5 JP2002516882A5 JP2000551817A JP2000551817A JP2002516882A5 JP 2002516882 A5 JP2002516882 A5 JP 2002516882A5 JP 2000551817 A JP2000551817 A JP 2000551817A JP 2000551817 A JP2000551817 A JP 2000551817A JP 2002516882 A5 JP2002516882 A5 JP 2002516882A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- peptidomimetic
- binds
- human
- grp receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 17
- 239000000816 peptidomimetic Substances 0.000 description 11
- 206010028980 Neoplasm Diseases 0.000 description 9
- 102400001175 Unique cartilage matrix-associated protein C-terminal fragment Human genes 0.000 description 9
- 206010006187 Breast cancer Diseases 0.000 description 7
- 208000026310 Breast neoplasm Diseases 0.000 description 7
- 206010027476 Metastases Diseases 0.000 description 7
- 206010060862 Prostate cancer Diseases 0.000 description 7
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 7
- 230000009401 metastasis Effects 0.000 description 7
- 210000000481 breast Anatomy 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 241000282412 Homo Species 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8807498P | 1998-06-05 | 1998-06-05 | |
| US60/088,074 | 1998-06-05 | ||
| US8851798P | 1998-06-08 | 1998-06-08 | |
| US60/088,517 | 1998-06-08 | ||
| PCT/US1999/012414 WO1999062563A2 (en) | 1998-06-05 | 1999-06-03 | Radiolabeled peptides for the diagnosis and treatment of breast and prostate tumors and metastases of such tumors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002516882A JP2002516882A (ja) | 2002-06-11 |
| JP2002516882A5 true JP2002516882A5 (https=) | 2006-07-20 |
| JP4295921B2 JP4295921B2 (ja) | 2009-07-15 |
Family
ID=26778250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000551817A Expired - Fee Related JP4295921B2 (ja) | 1998-06-05 | 1999-06-03 | 乳癌および前立腺癌、並びにそのような腫瘍の転移の診断および処置用放射能標識化ペプチド |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1001977B1 (https=) |
| JP (1) | JP4295921B2 (https=) |
| AT (1) | ATE305940T1 (https=) |
| CA (1) | CA2299389A1 (https=) |
| DE (1) | DE69927568T2 (https=) |
| DK (1) | DK1001977T3 (https=) |
| ES (1) | ES2247835T3 (https=) |
| WO (1) | WO1999062563A2 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6869591B2 (en) * | 2002-03-26 | 2005-03-22 | Barnes-Jewish Hospital | Paramagnetic particles that provide improved relaxivity |
| US8420050B2 (en) | 2003-01-13 | 2013-04-16 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
| US7850947B2 (en) | 2003-01-13 | 2010-12-14 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
| US7226577B2 (en) * | 2003-01-13 | 2007-06-05 | Bracco Imaging, S. P. A. | Gastrin releasing peptide compounds |
| US7922998B2 (en) | 2003-01-13 | 2011-04-12 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
| US7611692B2 (en) | 2003-01-13 | 2009-11-03 | Bracco Imaging S.P.A. | Gastrin releasing peptide compounds |
| JP5099919B2 (ja) * | 2005-11-29 | 2012-12-19 | マリンクロッド インコーポレイテッド | 二官能性金属キレートコンジュゲート |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750646A (en) * | 1987-09-24 | 1998-05-12 | The Administrators Of The Tulane Educational Fund | Bradykinin analogs with non-peptide bond |
| ES2070329T3 (es) * | 1989-07-20 | 1995-06-01 | Sandoz Ltd | Derivados de polipeptidos. |
-
1999
- 1999-06-03 WO PCT/US1999/012414 patent/WO1999062563A2/en not_active Ceased
- 1999-06-03 DK DK99955223T patent/DK1001977T3/da active
- 1999-06-03 ES ES99955223T patent/ES2247835T3/es not_active Expired - Lifetime
- 1999-06-03 DE DE69927568T patent/DE69927568T2/de not_active Expired - Lifetime
- 1999-06-03 JP JP2000551817A patent/JP4295921B2/ja not_active Expired - Fee Related
- 1999-06-03 EP EP99955223A patent/EP1001977B1/en not_active Expired - Lifetime
- 1999-06-03 CA CA002299389A patent/CA2299389A1/en not_active Abandoned
- 1999-06-03 AT AT99955223T patent/ATE305940T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cheung et al. | Anti-G (D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age. | |
| Paganelli et al. | Two-step tumour targetting in ovarian cancer patients using biotinylated monoclonal antibodies and radioactive streptavidin | |
| Meredith et al. | Pharmacokinetics, immune response, and biodistribution of iodine-131-labeled chimeric mouse/human IgG1, k 17-1A monoclonal antibody | |
| Thakur et al. | 99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans | |
| Esmaeli et al. | Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (Zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma | |
| Grant et al. | Targeting of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8: a pilot trial | |
| Hessenius et al. | Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours | |
| Cheung et al. | Targeting of ganglioside GD2Monoclonal antibody to neuroblastoma | |
| IL131386A0 (en) | Method for the detection and localization of malignant human tumours | |
| JP2005513416A5 (https=) | ||
| Lam et al. | Pentavalent 99Tcm-DMSA imaging in patients with bone metastases | |
| Nakamura et al. | Five-year survival after transcatheter chemoembolization for hepatocellular carcinoma | |
| Liu et al. | Lutetium Lu 177 vipivotide tetraxetan for prostate cancer | |
| JP2002516882A5 (https=) | ||
| Grana et al. | Radioimmunotherapy in advanced ovarian cancer: is there a role for pre-targeting with 90Y-biotin? | |
| Epenetos | Antibody guided lymphangiography in the staging of cervical cancer | |
| CN107690334A (zh) | 使用针对haah的抗体对癌症的放射成像和放射治疗 | |
| US20240342322A1 (en) | Netrin-1 detection, companion test and therapy based on radiations | |
| Draisma et al. | Gallium-67 as a Tumor-seeking Agent in Lymphomas-a Review | |
| McQuarrie et al. | Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H. 82: report of a phase II study | |
| Dadachova et al. | Update: Renaissance of Targeting Molecules for Melanoma | |
| Li et al. | Prelabeling of Chimeric Monoclonal Antibody L6 with 90Yttrium-and 111Indium-1, 4, 7, 10-tetraazacyclododecane-N, N′, N ″, N‴-tetraacetic acid (DOTA) Chelates for Radioimmunodiagnosis and Therapy | |
| DE60033697D1 (de) | Radiomarkierte vip-analoge zur diagnose und therapie | |
| Keenan | Immunolymphoscintigraphy | |
| Stein et al. | Manipulation of blood clearance to optimize delivery of residualizing label-antibody conjugates to tumor cells in vivo |